Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
Haosheng Zheng, Guojie Long, Yuzhen Zheng, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5344-5344
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

SLC2A1 boosts the resistance of non-small cell lung cancer to taxanes by stimulating the formation of EPCAM+ cancer stem-like cells via glycolysis
Zhe Yu, Jian Sun, Kai Fang, et al.
Translational Oncology (2024) Vol. 49, pp. 102082-102082
Open Access | Times Cited: 4
Integrative analysis of genetic variability and functional traits in lung adenocarcinoma epithelial cells via single-cell RNA sequencing, GWAS, bayesian deconvolution, and machine learning
Chuyue Gao, Jintao Wu, Fangyan Zhong, et al.
Genes & Genomics (2025)
Open Access
Single-cell analysis reveals landscape of endometrial cancer response to estrogen and identification of early diagnostic markers
Chunli Dong, Liyan Zhao, Xiongtao Liu, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0301128-e0301128
Open Access | Times Cited: 3
Advancements in the study of glucose metabolism in relation to tumor progression and treatment
Meng Zhao, Yulong Chen, Lian‐He Yang
Progress in Biophysics and Molecular Biology (2024) Vol. 192, pp. 11-18
Open Access | Times Cited: 3
Huanglian Jiedu Decoction enhances the stability of atherosclerotic plaques through SLC2A1-mediated efferocytosis
Guiting Zhou, Liwen Lin, Shushu Wang, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112834-112834
Open Access | Times Cited: 3
PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancer
Jian Peng, Pingping Li, Yuan Li, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Unveiling the potential of HSPA4: a comprehensive pan-cancer analysis of HSPA4 in diagnosis, prognosis, and immunotherapy
Junhao Yang, Xiaoxiao Wu, Jian‐Hong You
Aging (2024)
Open Access | Times Cited: 2
Recent Advancements in Research on DNA Methylation and Testicular Germ Cell Tumors: Unveiling the Intricate Relationship
Alina-Teodora Nicu, Ileana Paula Ionel, Ileana Stoica, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1041-1041
Open Access | Times Cited: 2
The lncRNA UCA1 Enhances Pancreatic Cancer EMT by Regulating miR-708-5p and miR-135b-5p: A Bioinformatics Approach
Nahid Askari, Marziye Shad pirouz, Vida Mafikandi, et al.
Iranian Journal of Public Health (2024)
Open Access | Times Cited: 2
Role of N6‐methyladenosine RNA modification in cancer
Yi Qu, Nannan Gao, Shengwei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 2
Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells
Meiqi Yang, Shuling Zhang, Li Sun, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
SLC12A8 mediates TKI resistance in EGFR-mutant lung cancer via PDK1/AKT axis
Fang Huang, Jian Cui, Jingxuan Wan, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 18, pp. 16729-16739
Closed Access | Times Cited: 5
Predicting potential therapeutic targets and small molecule drugs for early-stage lung adenocarcinoma
Yongxin Yu, Lingchen Li, Bangyu Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116528-116528
Open Access | Times Cited: 1
A novel anoikis-related gene signature can predict the prognosis of hepatocarcinoma patients
Xiaohan Yu, Bo Feng, Jinge Wu, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 4, pp. 1834-1847
Open Access | Times Cited: 1
Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients
Gabriele Perrone, Luigi Rigacci, Giandomenico Roviello, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
Proteomics Analysis of Interactions between Drug-Resistant and Drug-Sensitive Cancer Cells: Comparative Studies of Monoculture and Coculture Cell Systems
Zongkai Peng, Nagib Ahsan, Zhibo Yang
Journal of Proteome Research (2024) Vol. 23, Iss. 7, pp. 2608-2618
Closed Access | Times Cited: 1
Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344
Haosheng Zheng, Guojie Long, Yuzhen Zheng, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 586-586
Open Access | Times Cited: 3
Development of the prognostic value in lung adenocarcinoma based on anoikis‐related genes and initial experimental validation
Wenwei Guo, Guang Sheng Zhao, Suping Liu, et al.
The Journal of Gene Medicine (2023) Vol. 25, Iss. 9
Closed Access | Times Cited: 3
SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with 18F-FDG metabolic parameters
Yaohua Zhang, Xu‐Sheng Liu, Yan Gao, et al.
Lung Cancer (2023) Vol. 188, pp. 107449-107449
Closed Access | Times Cited: 3
Increased epithelial mTORC1 activity in chronic rhinosinusitis with nasal polyps
George Huang, Nils Hallen, Minkyu Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Unveiling the Role of SLC2A1 and MPST in Uterine Corpus Endometrial Carcinoma: Diagnostic and Prognostic Insights
Xiaoyu Xi, Xinxin Gong, Yixi Liu, et al.
Research Square (Research Square) (2024)
Open Access
Learning the Relationship Between Variants, Metabolic Fluxes and Phenotypes
Dong In Kim, Seokjin Han, Seong-Hyeuk Nam, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The emerging roles of circHECTD1 in human diseases and the specific underlying regulatory mechanisms
Yiran Yuan, Xiaomin Zhang, Xiaoxiao Wang, et al.
PeerJ (2024) Vol. 12, pp. e17612-e17612
Open Access
Overexpression of SLC2A1, ALDOC, and PFKFB4 in the glycolysis pathway drives strong drug resistance in 3D HeLa tumor cell spheroids
Tong Wang, Xueting Wang, Xuli Zheng, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 9
Closed Access
Machine learning and multi-omics characterization of SLC2A1 as a prognostic factor in hepatocellular carcinoma
Kangjie Xu, Houliang Zhang, Hua Dai, et al.
Gene (2024) Vol. 938, pp. 149178-149178
Closed Access
Page 1 - Next Page

Scroll to top